D441 Medical Dosage Calculations and Pharmacology - Set 3 - Part 3

Correct Answer: Dyskinesia from excess dopamine

dyskinesia, characterized by involuntary movements, is a sign of levodopa toxicity caused by excess dopamine in the brain, and indicates the medication dose may need adjustment by the provider. Option a is incorrect because worsening Parkinson's disease would present with increased rigidity, bradykinesia, and worsening tremors rather than new involuntary writhing movements, which indicate too much dopamine rather than too little. Option b is incorrect because tardive dyskinesia results from long-term use of dopamine-blocking antipsychotic medications, not from dopamine-increasing medications like levodopa, and the clinical context clearly points to levodopa-induced excess dopamine. Option c is incorrect because an allergic reaction to carbidopa would present with typical allergy symptoms such as rash, itching, or anaphylaxis rather than the specific pattern of involuntary writhing movements that characterize dopamine-related dyskinesia.

Correct Answer: Avoid high-protein meals with levodopa

high-protein meals compete with levodopa for absorption in the small intestine and transport across the blood-brain barrier, significantly reducing the medication's effectiveness in managing Parkinson's symptoms. Option b is incorrect because protein actually competes with levodopa for the same amino acid transport system, reducing rather than enhancing the drug's absorption and delivery to the brain where it is converted to dopamine. Option c is incorrect because restricting protein to breakfast only does not eliminate the interaction, and patients should be counseled to avoid high-protein meals throughout the day when taking levodopa to maintain consistent therapeutic drug levels. Option d is incorrect because protein significantly interferes with levodopa absorption and transport, and failing to educate the patient about this important drug-nutrient interaction could lead to subtherapeutic medication levels and poor symptom control.

Correct Answer: Tardive dyskinesia

tardive dyskinesia is characterized by involuntary facial movements including lip smacking, tongue twisting, puckering, and cheek bulging, caused by long-term use of dopamine-blocking antipsychotic medications. Option a is incorrect because medication-induced parkinsonism presents with tremors, rigidity, and bradykinesia similar to Parkinson's disease rather than the specific pattern of repetitive involuntary facial movements like lip smacking and tongue twisting. Option c is incorrect because acute dystonic reactions involve sudden sustained muscle contractions typically occurring early in antipsychotic therapy, not the gradual onset of repetitive involuntary facial movements seen after years of medication use. Option d is incorrect because serotonin syndrome presents with agitation, hyperthermia, rapid heart rate, and muscle rigidity from excess serotonin activity, not the specific involuntary orofacial movements characteristic of tardive dyskinesia.

Correct Answer: At nighttime before going to sleep

donepezil, an acetylcholinesterase inhibitor used to delay cognitive decline in Alzheimer's disease, is recommended to be administered at night to minimize gastrointestinal side effects like nausea and diarrhea. Option a is incorrect because donepezil is specifically recommended for nighttime administration rather than morning dosing, as taking it at bedtime helps the patient sleep through the initial gastrointestinal side effects of the medication. Option b is incorrect because donepezil should be given at bedtime, not at noon with meals, and the evening administration schedule is specifically designed to improve tolerability by allowing the patient to rest during peak side effect occurrence. Option d is incorrect because donepezil is administered once daily at bedtime, not every four hours, and around-the-clock dosing is not appropriate for this medication class used in Alzheimer's disease management for cognitive preservation.

Correct Answer: This discoloration is a normal expected effect

urine discoloration to red or brown is a well-documented and harmless side effect of levodopa therapy that does not indicate any dangerous condition, and the patient should be reassured and continue treatment. Option b is incorrect because dark reddish-brown urine is an expected and benign effect of levodopa, and sending the patient to the emergency department for this normal finding would cause unnecessary anxiety, expense, and healthcare resource use. Option c is incorrect because stopping levodopa therapy due to normal urine discoloration would deprive the patient of essential Parkinson's disease treatment, and this expected side effect does not warrant any change in the medication regimen. Option d is incorrect because while adequate hydration is generally good advice, the urine discoloration from levodopa is caused by drug metabolism rather than concentration, and increasing fluids will not prevent this normal pharmacological effect.

Correct Answer: Digoxin toxicity from low potassium

nausea, blurred vision, and appetite loss are classic signs of digoxin toxicity, and hypokalemia with a potassium of three point two significantly increases toxicity risk since low potassium enhances digoxin's toxic effects. Option a is incorrect because the combination of nausea, blurred vision, and appetite loss in a patient on digoxin therapy with concurrent hypokalemia follows the classic pattern of digoxin toxicity rather than a coincidental gastrointestinal illness. Option b is incorrect because while heart failure can cause appetite changes and nausea, the specific combination with blurred vision and documented hypokalemia strongly points to digoxin toxicity as the underlying cause requiring immediate intervention. Option c is incorrect because a potassium level of three point two indicates hypokalemia, not potassium overdose, and this low level actually increases the risk of digoxin toxicity because potassium and digoxin compete for the same cardiac binding sites.

Correct Answer: Rhabdomyolysis

severe muscle pain combined with cola-colored urine are hallmark signs of rhabdomyolysis, a serious adverse effect of statin drugs involving skeletal muscle breakdown that releases myoglobin into the bloodstream and urine. Option a is incorrect because while mild muscle discomfort can occur with statin therapy, severe muscle pain combined with dark cola-colored urine indicates rhabdomyolysis rather than expected soreness, and requires immediate medical evaluation and reporting. Option b is incorrect because deep vein thrombosis typically presents with unilateral leg swelling, warmth, and pain rather than bilateral severe muscle pain with cola-colored urine, which specifically suggests skeletal muscle breakdown from statin therapy. Option d is incorrect because hepatotoxicity from statins would present with jaundice, elevated liver enzymes, and abdominal symptoms rather than the combination of severe muscle pain with dark cola-colored urine that characterizes rhabdomyolysis.

Correct Answer: Take vitamin C to enhance absorption

vitamin C enhances the absorption of oral iron supplements by converting ferric iron to its more absorbable ferrous form, though the two should not be taken at exactly the same time together. Option b is incorrect because milk contains calcium which inhibits iron absorption, and taking ferrous sulfate with dairy products would significantly reduce the amount of iron the body can absorb from the supplement and worsen anemia treatment. Option c is incorrect because calcium-containing antacids interfere with iron absorption by binding to iron in the gastrointestinal tract, and antacids also alter stomach pH which further impairs the conditions needed for optimal iron absorption. Option d is incorrect because iron supplements should be taken on an empty stomach and one hour before other medications for maximum absorption, not after a heavy meal which would decrease bioavailability of the iron supplement.

Correct Answer: Nephrotoxicity and hepatotoxicity

cyclosporine requires monitoring of creatinine and BUN for nephrotoxicity and AST/ALT for hepatotoxicity, and the rising values in both kidney and liver markers indicate these organ systems are being damaged by the drug. Option a is incorrect because cardiotoxicity and pulmonary fibrosis are not the primary organ toxicities monitored with cyclosporine therapy, which specifically targets renal function through creatinine and BUN and liver function through AST and ALT values. Option c is incorrect because ototoxicity and neurotoxicity are concerns associated with medications like vancomycin and aminoglycosides rather than cyclosporine, which primarily affects kidney and liver function as its major organ toxicity concerns. Option d is incorrect because pancreatic and splenic damage are not the primary monitoring concerns for cyclosporine therapy, which focuses on renal function assessed by creatinine and BUN and hepatic function assessed by AST and ALT levels.

Correct Answer: Caffeine and beta-blockers must both be avoided

theophylline therapy requires avoiding both caffeine, which compounds the cardiac stimulant effects causing tachycardia, and beta-blockers like atenolol, which are specifically contraindicated with this methylxanthine medication. Option a is incorrect because caffeine is specifically listed as a substance to avoid during theophylline therapy since both are methylxanthines that stimulate the heart, and the patient's daily coffee consumption is directly contributing to the rapid heart rate. Option b is incorrect because beta-blockers do not enhance theophylline's therapeutic effects but rather create a dangerous contraindicated interaction, and atenolol is specifically identified as a medication that must be avoided with theophylline therapy. Option c is incorrect because while theophylline can cause tachycardia, the combination of a rapid heart rate with concurrent caffeine use and beta-blocker therapy represents a concerning clinical picture that requires provider notificatio